SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-09-001112
Filing Date
2009-08-31
Accepted
2009-08-31 11:42:28
Documents
9
Period of Report
2009-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 14913
2 ANNUAL FINANCIAL STATEMENTS ex991.htm EX-99.1 996806
3 MANAGEMENT DISCUSSION AND ANALYSIS ex992.htm EX-99.2 308882
4 ANNUAL INFORMATION FORM ex993.htm EX-99.3 469901
5 CEO/CFO CERTIFICATION ex994.htm EX-99.4 46314
6 LOGO kpmg.jpg GRAPHIC 9755
7 GRAPHIC sig.jpg GRAPHIC 2961
8 GRAPHIC graph.jpg GRAPHIC 32058
9 LOGO lorus.jpg GRAPHIC 11681
  Complete submission text file 0001279569-09-001112.txt   1916752
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 091044975
SIC: 2836 Biological Products, (No Diagnostic Substances)